Opthea (ASX: OPT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Opthea Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Opthea (ASX: OPT)
    Latest News

    Shot of a scientist using a computer while conducting research in a laboratory.
    Healthcare Shares

    'Exciting prospect': 2 ASX pharmaceutical shares to keep a close eye on

    These companies have developed new drugs to treat vision loss and erectile dysfunction.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Atlas Arteria, Coles, Healius, and Opthea shares are falling today

    Let's find out why investors are hitting the sell button today.

    Read more »

    Excited group of friends watching sports on TV and celebrating.
    Share Gainers

    Why Appen, Lotus, Opthea, and Paladin Energy shares are surging today

    These shares are starting the week with a bang. But why?

    Read more »

    A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Lotus Resources, Opthea, Qoria, and Sims shares are charging higher today

    These shares are catching the eye on Thursday. But why?

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why ARB, Guzman Y Gomez, Opthea, and Yancoal shares are storming higher

    These shares are starting the week with a bang. But why?

    Read more »

    Two lab workers fist pump each other.
    Healthcare Shares

    2 promising small-cap ASX healthcare stocks to buy now

    Theses two small-cap ASX healthcare shares could tap into the huge US medical market.

    Read more »

    surprised asx investor appearing incredulous at hearing asx share price
    Speculative

    'Blockbuster opportunity': This speculative ASX stock could rise 70%

    Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Atturra, Bravura, Core Lithium, and Opthea shares are racing higher today

    These shares are starting the week with a bang. What's happening?

    Read more »

    a business man in a suit holds his hand over his eyes as he bows his head in a defeated post suggesting regret and remorse.
    Share Fallers

    Why Core Lithium, Deterra Royalties, Northern Star, and Opthea shares are dropping

    These shares are ending the week deep in the red. But why?

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why A2 Milk, Lindsay Australia, Meridian Energy, and Opthea shares are falling today

    These ASX shares are having a tough time on Thursday. But why?

    Read more »

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Share Fallers

    Why Opthea, Pantoro, Premier Investments, and Wildcat shares are falling

    These ASX shares are having a tough time on Tuesday. But why?

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why APA Group, Cettire, Deep Yellow, and Opthea shares are falling today

    These ASX shares are having a difficult session. Here's what's happening.

    Read more »

    Frequently Asked Questions

    No, Opthea does not pay shareholder dividends at this time.

    Opthea Limited listed on the ASX on 18 April 1991. 

    OPT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Opthea

    Opthea Limited (ASX: OPT) is a clinical-stage biopharmaceutical company. Following the failure of its Phase 3 wet age-related macular degeneration (AMD) trials, the company discontinued that program and relaunched in June 2026 with a new focus on OPT-302 as a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung disease.

    Shareholders have been asked to approve a proposed name change to Ceryvyn Therapeutics to reflect the new direction.

    OPT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    08 Jul 2026 $0.01 $0.00 0.00% 7,777,329 $0.01 $0.02 $0.01
    07 Jul 2026 $0.01 $0.00 0.00% 4,723,387 $0.02 $0.02 $0.01
    06 Jul 2026 $0.02 $0.00 0.00% 9,873,809 $0.02 $0.02 $0.01
    03 Jul 2026 $0.01 $0.00 0.00% 3,708,050 $0.02 $0.02 $0.01
    02 Jul 2026 $0.02 $0.00 0.00% 19,796,064 $0.02 $0.02 $0.01
    01 Jul 2026 $0.01 $0.00 0.00% 27,096,878 $0.02 $0.02 $0.01

    Profile

    since

    Note